Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised the firm’s price target on Cidara Therapeutics (CDTX) to $35 from $24 and keeps a Buy rating on the ...
Solid Biosciences price target raised to $20 from $16 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Solid Biosciences (SLDB) to $20 from $16 and keeps a Buy rating on the shares following the ...